SCHEMBL6136706

SCHEMBL6136706

CC(NC(=O)Cc1cc(Cl)cc(Cl)c1)C(=O)O

nearest known ligand 0.46

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
THRA P10827 2/20 0.46
THRB P10828 2/20 0.46
SHMT1 P34896 1/20 0.46
SHMT2 P34897 1/20 0.46
GRN P28799 3/20 0.44
SORT1 Q99523 3/20 0.44
KDM4E B2RXH2 1/20 0.43
ALDH1A1 P00352 1/20 0.43
SMN1; SMN2 Q16637 1/20 0.43
KDM4C Q9H3R0 1/20 0.43
HSD17B10 Q99714 1/20 0.43
CNR2 P34972 4/20 0.42
ACLY P53396 1/20 0.41
CCKBR P32239 1/20 0.41
CTSK P43235 1/20 0.40
TACR1 P25103 1/20 0.40
POLB P06746 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6136711 1.00 THRA (0.46) THRATHRBSHMT1SHMT2GRN
SCHEMBL4414835 0.84 ALDH1A1 (0.52) SHMT1SHMT2ALDH1A1SMN1; SMN2KDM4C
SCHEMBL4414837 0.84 ALDH1A1 (0.52) SHMT1SHMT2ALDH1A1SMN1; SMN2KDM4C
SCHEMBL6136330 0.83 CNR2 (0.61) SHMT1SHMT2ALDH1A1CNR2POLB
SCHEMBL6136328 0.83 CNR2 (0.61) SHMT1SHMT2ALDH1A1CNR2POLB
SCHEMBL4417385 0.80 ALDH1A1 (0.40) THRATHRBGRNSORT1ALDH1A1
SCHEMBL6136789 0.80 ALDH1A1 (0.40) THRATHRBGRNSORT1ALDH1A1
SCHEMBL3088596 0.80 SMYD3 (0.48) THRATHRBKDM4EALDH1A1
SCHEMBL4106052 0.80 SMYD3 (0.48) THRATHRBKDM4EALDH1A1
SCHEMBL14367229 0.80 SMYD3 (0.48) THRATHRBKDM4EALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0951464-B1 N-(ARYL/HETEROARYLACETYL) AMINO ACID ESTERS, PHARMACEUTICAL COMPOSITIONS COMPRISING SAME, AND METHODS FOR INHIBITING BETA-AMYLOID PEPTIDE RELEASE AND/OR ITS SYNTHESIS BY USE OF SUCH COMPOUNDS ELAN PHARM INC (US) 2005-05-11 EP claimed